DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 3Dr. Reddy's Laboratories
02 4Alfred E Tiefenbacher GmbH
03 2Breckenridge Pharmaceutical
04 2Bal Pharma
05 2ANGITA PHARMA INC.
06 6Accord healthcare
07 1Ananta Medicare
08 4Apotex Inc
09 2Auro Pharma Inc
10 2Aurobindo Pharma Limited
11 2Austell Laboratories
12 2BIOMED 2002 INC
13 2Bionpharma
14 2Bluepharma
15 4Bristol Laboratories Ltd
16 38Bristol Myers Squibb
17 2Cipla Medpro South Africa
18 2Dr Reddy's Laboratories (Pty) Ltd
19 2Dr Seidel Life Science
20 1Eqova
21 1Evertogen
22 2Farmaprojects S.A.U
23 2Hetero Drugs
24 2INNOVATA PHARMACEUTICALS
25 2Impax Laboratories
26 2Indoco Remedies Limited
27 2Intas Pharmaceuticals
28 2JAMP PHARMA
29 2Laboratoire Riva
30 2Laboratorio Eczane Pharma
31 2MANTRA PHARMA INC
32 2MARCAN PHARMACEUTICALS INC
33 2MINT PHARMACEUTICALS INC
34 2Macleods Pharmaceuticals Limited
35 2Medichem S.A
36 2Micro Labs Limited
37 2Natco Pharma (Canada) Inc
38 4Nora Pharma
39 2PRO DOC LIMITEE
40 2Pfizer Inc
41 1Prinston
42 5Pulse Pharmaceuticals
43 2SANIS HEALTH INC
44 2SIVEM PHARMACEUTICALS ULC
45 4Sandoz B2B
46 1ScieGen Pharmaceuticals
47 2Sigmapharm Laboratories, LLC
48 1Stivaph Healthcare
49 6Sun Pharmaceutical Industries Limited
50 2Sunshine Lake Pharma
51 2Tecnimede
52 3Teva Pharmaceutical Industries
53 2Titan Laboratories
54 4Torrent Pharmaceuticals Limited
55 2Viatris
56 2Wanbang Biopharmaceuticals
57 2Zentiva
58 1Zhejiang Yongning Pharmaceutical Co., Lt
59 2Zydus Lifesciences
60 2Zydus Pharmaceuticals
01 11Antic-calc Tablet, Film Coated
02 1Apixaban 2,5Mg 10 Units Oral Use
03 1Apixaban 2,5Mg 20 Joined' Oral Use
04 1Apixaban 2,5Mg 60 Units Oral Use
05 1Apixaban 5Mg 28 Combined Oral Use
06 1Apixaban 5Mg 60 Units Oral Use
07 2Coated Tablet
08 14FCT
09 2FILM COATED PILL
10 1FOR SUSPENSION;ORAL
11 10Film Coated Tablet
12 2Film Coated Tablet
13 7Film-Coated Tablets
14 2Oral Solid Dosage Form
15 1SUSPENSION;ORAL
16 4TAB
17 40TABLET
18 1TABLET, FOR SUSPENSION;ORAL
19 6TABLET; ORAL
20 35TABLET;ORAL
21 21Tablet
22 2Tablets
23 3tablet
24 5Blank
01 16DISCN
02 4EU Dossier Readiness-Q4 2018
03 16Generic
04 2Lead Market Dossiers- Filed
05 2Originator
06 40Prescription
07 14RX
08 80Blank
01 2ACH-APIXABAN
02 2AG-APIXABAN
03 41APIXABAN
04 1APIXABAN 2,5 DRL
05 1APIXABAN 5 DRL
06 2APO-APIXABAN
07 2AURO-APIXABAN
08 3Apixaban
09 1Apixaban 2,5 Accord
10 1Apixaban 5 Accord
11 2BIO-APIXABAN
12 1Deksel CD
13 10ELIQUIS
14 1ELIQUIS SPRINKLE
15 1EPLIPIX 2,5
16 1EPLIPIX 5
17 5Eliqs
18 26Eliquis
19 1Eliquis 2.5 mg
20 1Eliquis 5 mg
21 2Emboxan
22 1Fibranix 2,5
23 1Fibranix 5
24 1INNOKLOD 2,5
25 1INNOKLOD 5
26 2JAMP APIXABAN
27 2M-APIXABAN
28 2MAR-APIXABAN
29 2MINT-APIXABAN
30 2NAT-APIXABAN
31 2NRA-APIXABAN
32 2NRA-APIXABAN TABLETS
33 1PIXECLOT 2.5 mg
34 1PIXECLOT 5 mg
35 2PRO-APIXABAN
36 2RIVA APIXABAN
37 2SANDOZ APIXABAN SDZ
38 2TARO-APIXABAN
39 2TEVA-APIXABAN
40 2Thromboxan
41 2Xanza
42 1Xarpix 2,5
43 1Xarpix 5
44 1Zyquis 2.5
45 1Zyquis 5
46 29Blank
01 2Argentina
02 8Australia
03 40Canada
04 2China
05 2Czech Republic
06 6Germany
07 19India
08 5Italy
09 11Norway
10 4Portugal
11 18South Africa
12 4Spain
13 2Sweden
14 7Switzerland
15 44USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET; ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number : 210082
Regulatory Info :
Registration Country : USA
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Regulatory Info : DISCN
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2021-07-26
Application Number : 209845
Regulatory Info : DISCN
Registration Country : USA
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Regulatory Info :
Registration Country : India
Brand Name : Apixaban
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Regulatory Info : DISCN
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2021-07-26
Application Number : 209845
Regulatory Info : DISCN
Registration Country : USA
Bal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.
Regulatory Info :
Registration Country : India
Brand Name : Apixaban
Dosage Form : Tablet
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : ELIQUIS
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2012-12-28
Application Number : 202155
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ELIQUIS
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2012-12-28
Application Number : 202155
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ELIQUIS
Dosage Form : TABLET, FOR SUSPENSION;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date : 2025-04-17
Application Number : 202155
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2025-02-14
Application Number : 209810
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2025-02-14
Application Number : 209810
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2020-09-11
Application Number : 209898
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2020-09-11
Application Number : 209898
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 2.GMG
Packaging :
Approval Date :
Application Number : 209944
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number : 209944
Regulatory Info :
Registration Country : USA
